J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

Johnson & ⁠Johnson also increased its full-year sales and ⁠profit ‌forecast.

You are being sent to the original publisher. FX Radar keeps this reference for market context and source discovery.